# Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Funduscopic Images

> **NCT05857943** · NA · COMPLETED · sponsor: **AEYE Health Inc** · enrollment: 363 (actual)

## Conditions studied

- Diabetes Mellitus
- Diabetic Retinopathy

## Interventions

- **DEVICE:** AEYE-DS Software

## Key facts

- **NCT ID:** NCT05857943
- **Lead sponsor:** AEYE Health Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-29
- **Primary completion:** 2023-09-11
- **Final completion:** 2023-10-10
- **Target enrollment:** 363 (ACTUAL)
- **Last updated:** 2023-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05857943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05857943, "Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Funduscopic Images". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05857943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*